放射線治療の世界市場レポート 2025年

放射線治療市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.9％で、103億5,000万米ドルに成長します。この予測期間における成長は、先進ヘルスケア技術への投資の増加、低侵襲治療オプションへの注目の高まり、在宅ヘルスケアソリューションへの需要の高まり、品質保証プログラムの重視の高まり、がん医療に取り組む世界ヘルスイニシアチブの拡大などが牽引すると予想されます。主な動向としては、画像誘導による放射線治療の発展、粒子線治療の進歩、新しいブラキセラピー技術の開発、サイバーナイフ技術の革新、治療計画における人工知能の統合などが挙げられます。

がん罹患率の上昇が放射線治療市場の拡大を牽引すると予測されています。がんは、体の他の部分に浸潤・転移し、さまざまな組織や臓器に影響を及ぼし、さまざまな症状を引き起こす異常な細胞の無秩序な増殖を特徴とする疾患です。がんの罹患率の増加は、人口の高齢化、食生活の乱れや運動不足を含むライフスタイルの変化、タバコやアルコールの多量摂取、環境汚染、早期発見を可能にする診断ツールの進歩などの要因と関連しています。放射線治療は、がん細胞を正確に標的にして破壊し、腫瘍を小さくして患者の予後を改善することで、がん治療において重要な役割を果たしています。例えば、2024年8月、がん患者を支援する英国の慈善団体マクミラン・キャンサー・サポートは、英国で300万人以上ががんと共に生きていると報告し、2025年までに350万人、2030年までに400万人、2040年までに530万人に増加すると予測しています。その結果、がんの有病率の上昇が放射線治療市場の成長に拍車をかけています。

放射線治療市場の主要企業は、画像誘導放射線治療（IGRT）などの革新的技術の開発を優先し、治療の精度を高め、患者の転帰を改善し、周囲の健康な組織へのダメージを最小限に抑えています。IGRTは、放射線治療中の正確な腫瘍ターゲティングを確実にするために高度な画像ツールを利用し、精度を高めるために腫瘍の位置をリアルタイムで追跡・調整することを可能にします。例えば、2022年5月、スウェーデンの医療技術企業であるElekta ABは、定位放射線手術の機能を強化する次世代放射線手術システムであるElekta Espritを発表しました。このシステムは、複数の革新的技術を単一のプラットフォームに統合し、治療チームに優れた可視化とリモートアクセスを提供します。シングルセッション、分割、適応、段階的プロトコルを含む柔軟なワークフローオプションをサポートし、臨床現場での使いやすさと効率を最適化します。0.3mm以下の精度で、周囲の健康な組織を温存しながら、最も困難な課題も治療できるように設計されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界放射線治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の放射線治療市場：成長率分析
• 世界の放射線治療市場の実績：規模と成長, 2019-2024
• 世界の放射線治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界放射線治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の放射線治療市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外部放射線療法
• 内部照射療法
• 全身放射線療法
• 世界の放射線治療市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前立腺がん
• 乳がん
• 肺がん
• 頭頸部がん
• 大腸がん
• 婦人科がん
• 子宮頸がん
• 陰茎がん
• その他の用途
• 世界の放射線治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院および診断検査室
• がん治療・研究センター
• 学術調査機関
• 外来手術センター
• その他のエンドユーザー
• 世界の放射線治療市場外部放射線治療の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 強度変調放射線治療（IMRT）
• 定位放射線治療（SBRT）
• 3Dコンフォーマル放射線治療（3D-CRT）
• 陽子線治療
• 画像誘導放射線治療（IGRT）
• 体積変調アーク治療（VMAT）
• 世界の放射線治療市場内部照射放射線治療の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 密封小線源治療（高線量率）
• 密封小線源治療（低線量率）
• 術中放射線療法（IORT）
• 永久種子インプラント
• 世界の放射線治療市場全身放射線療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 放射性同位元素療法
• 標的放射性核種療法
• 放射免疫療法
• ペプチド受容体放射性核種療法（PRRT）

第7章 地域別・国別分析

• 世界の放射線治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の放射線治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 放射線治療市場：競合情勢
• 放射線治療市場：企業プロファイル
  • Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sumitomo Heavy Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Elekta AB
• Accuray Incorporated
• Ion Beam Applications S.A
• Canon Medical Systems Corporation
• RefleXion Medical Inc.
• Mevion Medical Systems Inc.
• Nordion Inc.
• Theragenics Corporation
• RaySearch Laboratories AB
• MIM Software Inc.
• Vision RT Ltd.
• Sun Nuclear Corporation
• Provision Healthcare LLC
• Panacea Medical Technologies Pvt. Ltd.
• Optivus Proton Therapy Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 放射線治療市場2029：新たな機会を提供する国
• 放射線治療市場2029：新たな機会を提供するセグメント
• 放射線治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Radiotherapy is a medical treatment that utilizes high doses of radiation to destroy cancer cells and shrink tumors. It is commonly used to treat various types of cancer, either as a standalone therapy or in combination with surgery and chemotherapy.

The primary types of radiotherapy include external beam radiation therapy, internal beam radiation therapy, and systemic radiation therapy. External beam radiation therapy delivers high-energy radiation from an external machine to target and destroy cancer cells. This treatment is applied to various cancers, including prostate, breast, lung, head and neck, colorectal, gynecological, cervical, and penile cancers, among others. It is used by multiple end users, such as hospitals and diagnostic labs, cancer treatment and research centers, academic institutions, and ambulatory surgery centers.

The radiotherapy market research report is one of a series of new reports from The Business Research Company that provides radiotherapy market statistics, including the radiotherapy industry's global market size, regional shares, competitors with a radiotherapy market share, detailed radiotherapy market segments, market trends and opportunities, and any further data you may need to thrive in the radiotherapy industry. This radiotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The radiotherapy market size has grown strongly in recent years. It will grow from $7.38 billion in 2024 to $7.92 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period was driven by the increasing incidence of cancer cases worldwide, rising demand for non-invasive cancer treatments, expansion of healthcare infrastructure, greater adoption of personalized medicine, and a growing patient population requiring cancer treatment.

The radiotherapy market size is expected to see strong growth in the next few years. It will grow to $10.35 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period is expected to be driven by increasing investment in advanced healthcare technologies, a growing focus on minimally invasive treatment options, rising demand for home-based healthcare solutions, an increasing emphasis on quality assurance programs, and expanding global health initiatives addressing cancer care. Key trends include advancements in image-guided radiotherapy, progress in particle therapy, the development of novel brachytherapy techniques, innovations in CyberKnife technology, and the integration of artificial intelligence in treatment planning.

The rising prevalence of cancer is anticipated to drive the expansion of the radiotherapy market. Cancer is a disease characterized by the uncontrolled growth of abnormal cells that can invade and spread to other parts of the body, affecting various tissues and organs and leading to a wide range of symptoms. The increasing incidence of cancer is linked to factors such as an aging population, lifestyle changes including poor diet and physical inactivity, high tobacco and alcohol consumption, environmental pollution, and advancements in diagnostic tools that enable earlier detection. Radiotherapy plays a vital role in cancer treatment by precisely targeting and destroying cancerous cells, reducing tumor size, and improving patient outcomes. For example, in August 2024, Macmillan Cancer Support, a UK-based charitable organization supporting cancer patients, reported that more than 3 million people in the UK were living with cancer, with projections indicating an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As a result, the rising prevalence of cancer is fueling the growth of the radiotherapy market.

Leading companies in the radiotherapy market are prioritizing the development of innovative technologies, such as image-guided radiotherapy (IGRT), to enhance treatment precision, improve patient outcomes, and minimize damage to surrounding healthy tissues. IGRT utilizes advanced imaging tools to ensure accurate tumor targeting during radiation therapy, allowing real-time tracking and adjustments to the tumor's position for increased precision. For instance, in May 2022, Elekta AB, a Sweden-based medical technology company, introduced the Elekta Esprit, a next-generation radiosurgery system that enhances the capabilities of stereotactic radiosurgery. This system integrates multiple innovations into a single platform, offering superior visualization and remote accessibility for treatment teams. It supports flexible workflow options, including single-session, fractionated, adaptive, or staged protocols, optimizing ease of use and efficiency in clinical settings. With an accuracy of less than 0.3 mm, the system is designed to treat even the most challenging targets while preserving surrounding healthy tissues.

In February 2024, Bristol Myers Squibb, a US-based pharmaceutical company, acquired RayzeBio Inc. for an undisclosed amount. This acquisition strengthens its oncology pipeline with advanced radiopharmaceutical therapeutics, including RYZ101, which targets SSTR2 in GEP-NETs and ES-SCLC. With ongoing clinical trials and a state-of-the-art manufacturing facility, this strategic move enables Bristol Myers Squibb to accelerate innovation, expand treatment options, and drive growth in the oncology sector. RayzeBio Inc. is a US-based company specializing in the development of innovative radiopharmaceuticals for cancer treatment.

Major players in the radiotherapy market are Hitachi Ltd., Koninklijke Philips N.V., GE Healthcare Technologies Inc., Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Ion Beam Applications S.A, Canon Medical Systems Corporation, RefleXion Medical Inc., Mevion Medical Systems Inc., Nordion Inc., Theragenics Corporation, RaySearch Laboratories AB, MIM Software Inc., Vision RT Ltd., Sun Nuclear Corporation, Provision Healthcare LLC, Panacea Medical Technologies Pvt. Ltd., Optivus Proton Therapy Inc., Perspective Therapeutics Inc., GT Medical Technologies Inc., ProTom International Inc.

North America was the largest region in the radiotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in radiotherapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the radiotherapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The radiotherapy market includes revenues earned by entities by providing services such as brachytherapy, palliative radiotherapy, proton therapy, and intraoperative radiotherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The radiotherapy market consists of sales of patient positioning systems, surface-guided radiation therapy systems (SGRT), CT and MRI simulation systems, and linear accelerators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Radiotherapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on radiotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for radiotherapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The radiotherapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Therapy Type: External Beam Radiation Therapy; Internal Beam Radiation Therapy; Systemic Radiation Therapy
• 2) By Application: Prostate Cancer; Breast Cancer; Lung Cancer; Head And Neck Cancer; Colorectal Cancer; Gynecological Cancer; Cervical Cancer; Penile Cancer; Other Applications
• 3) By End-User: Hospitals And Diagnostic Laboratories; Cancer Treatment And Research Centers; Academic Research Organizations; Ambulatory Surgery Centers; Other End-Users
• Subsegments:
• 1) By External Beam Radiation Therapy: Intensity-Modulated Radiation Therapy (IMRT); Stereotactic Body Radiation Therapy (SBRT); 3D Conformal Radiation Therapy (3D-CRT); Proton Beam Therapy; Image-Guided Radiation Therapy (IGRT); Volumetric Modulated Arc Therapy (VMAT)
• 2) By Internal Beam Radiation Therapy: Brachytherapy (High-Dose Rate); Brachytherapy (Low-Dose Rate); Intraoperative Radiation Therapy (IORT); Permanent Seed Implants
• 3) By Systemic Radiation Therapy: Radioisotope Therapy; Targeted Radionuclide Therapy; Radioimmunotherapy; Peptide Receptor Radionuclide Therapy (PRRT)
• Companies Mentioned:Hitachi Ltd.; Koninklijke Philips N.V.; GE Healthcare Technologies Inc.; Sumitomo Heavy Industries Ltd.; Varian Medical Systems Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Radiotherapy Market Characteristics

3. Radiotherapy Market Trends And Strategies

4. Radiotherapy Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Radiotherapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Radiotherapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Radiotherapy Market Growth Rate Analysis
• 5.4. Global Radiotherapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Radiotherapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Radiotherapy Total Addressable Market (TAM)

6. Radiotherapy Market Segmentation

• 6.1. Global Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• External Beam Radiation Therapy
• Internal Beam Radiation Therapy
• Systemic Radiation Therapy
• 6.2. Global Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Head And Neck Cancer
• Colorectal Cancer
• Gynecological Cancer
• Cervical Cancer
• Penile Cancer
• Other Applications
• 6.3. Global Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Diagnostic Laboratories
• Cancer Treatment And Research Centers
• Academic Research Organizations
• Ambulatory Surgery Centers
• Other End-Users
• 6.4. Global Radiotherapy Market, Sub-Segmentation Of External Beam Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intensity-Modulated Radiation Therapy (IMRT)
• Stereotactic Body Radiation Therapy (SBRT)
• 3D Conformal Radiation Therapy (3D-CRT)
• Proton Beam Therapy
• Image-Guided Radiation Therapy (IGRT)
• Volumetric Modulated Arc Therapy (VMAT)
• 6.5. Global Radiotherapy Market, Sub-Segmentation Of Internal Beam Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Brachytherapy (High-Dose Rate)
• Brachytherapy (Low-Dose Rate)
• Intraoperative Radiation Therapy (IORT)
• Permanent Seed Implants
• 6.6. Global Radiotherapy Market, Sub-Segmentation Of Systemic Radiation Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Radioisotope Therapy
• Targeted Radionuclide Therapy
• Radioimmunotherapy
• Peptide Receptor Radionuclide Therapy (PRRT)

7. Radiotherapy Market Regional And Country Analysis

• 7.1. Global Radiotherapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Radiotherapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Radiotherapy Market

• 8.1. Asia-Pacific Radiotherapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Radiotherapy Market

• 9.1. China Radiotherapy Market Overview
• 9.2. China Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Radiotherapy Market

• 10.1. India Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Radiotherapy Market

• 11.1. Japan Radiotherapy Market Overview
• 11.2. Japan Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Radiotherapy Market

• 12.1. Australia Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Radiotherapy Market

• 13.1. Indonesia Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Radiotherapy Market

• 14.1. South Korea Radiotherapy Market Overview
• 14.2. South Korea Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Radiotherapy Market

• 15.1. Western Europe Radiotherapy Market Overview
• 15.2. Western Europe Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Radiotherapy Market

• 16.1. UK Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Radiotherapy Market

• 17.1. Germany Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Radiotherapy Market

• 18.1. France Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Radiotherapy Market

• 19.1. Italy Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Radiotherapy Market

• 20.1. Spain Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Radiotherapy Market

• 21.1. Eastern Europe Radiotherapy Market Overview
• 21.2. Eastern Europe Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Radiotherapy Market

• 22.1. Russia Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Radiotherapy Market

• 23.1. North America Radiotherapy Market Overview
• 23.2. North America Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Radiotherapy Market

• 24.1. USA Radiotherapy Market Overview
• 24.2. USA Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Radiotherapy Market

• 25.1. Canada Radiotherapy Market Overview
• 25.2. Canada Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Radiotherapy Market

• 26.1. South America Radiotherapy Market Overview
• 26.2. South America Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Radiotherapy Market

• 27.1. Brazil Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Radiotherapy Market

• 28.1. Middle East Radiotherapy Market Overview
• 28.2. Middle East Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Radiotherapy Market

• 29.1. Africa Radiotherapy Market Overview
• 29.2. Africa Radiotherapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Radiotherapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Radiotherapy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Radiotherapy Market Competitive Landscape And Company Profiles

• 30.1. Radiotherapy Market Competitive Landscape
• 30.2. Radiotherapy Market Company Profiles
  • 30.2.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GE Healthcare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sumitomo Heavy Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Radiotherapy Market Other Major And Innovative Companies

• 31.1. Elekta AB
• 31.2. Accuray Incorporated
• 31.3. Ion Beam Applications S.A
• 31.4. Canon Medical Systems Corporation
• 31.5. RefleXion Medical Inc.
• 31.6. Mevion Medical Systems Inc.
• 31.7. Nordion Inc.
• 31.8. Theragenics Corporation
• 31.9. RaySearch Laboratories AB
• 31.10. MIM Software Inc.
• 31.11. Vision RT Ltd.
• 31.12. Sun Nuclear Corporation
• 31.13. Provision Healthcare LLC
• 31.14. Panacea Medical Technologies Pvt. Ltd.
• 31.15. Optivus Proton Therapy Inc.

32. Global Radiotherapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Radiotherapy Market

34. Recent Developments In The Radiotherapy Market

35. Radiotherapy Market High Potential Countries, Segments and Strategies

• 35.1 Radiotherapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Radiotherapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Radiotherapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer